SI
Syncromune, Inc.
SEC filingBiotechnology · Fort Lauderdale, FL
Amount raised$144.8Msold at filing
Total offering$144.8M
Investors in the raise77count reported to the SEC
FiledMay 11, 2026first sale Dec 3, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Joseph J. GerardiExecutive Officer
Jeffrey L. ClelandDirector
Douglas G. WatsonDirector
Joseph C. MaroonDirector
Stephen L. DaleExecutive Officer
Norman L. SchwartzDirector
Charles J. LinkExecutive Officer, Director
Eamonn J. HobbsExecutive Officer, Director
Kerri-Ann L. MillarExecutive Officer
Agustin J. GagoExecutive Officer
Executive officers, directors and promoters as listed on the Form D.